Skip to Main Content

WASHINGTON — Former FDA Commissioner Scott Gottlieb said so-called continuous manufacturing would prevent drug shortages, lower drug prices, and bring manufacturing back to the United States. Lawmakers have doled out millions to encourage it. There are predictions it could throw gasoline on the quest for flu treatments and now, potentially, coronavirus therapies.

So why aren’t most drug makers fully bought in?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!